Article Cited by others


Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer

Le Jesse D, Huang Jiaoti, Marks Leonard S

Year : 2014| Volume: 16| Issue : 4 | Page no: 522-529

   This article has been cited by
1 Cognitive mpMRI/TRUS biopsy of the prostate with using strain elastography
A. V. Vasilev,A. V. Mishchenko,R. A. Kadyrleev,A. S. Petrova,A. K. Nosov,S. A. Reva,V. V. Danilov,M. V. Berkut
Medical Visualization. 2019; (2): 100
[Pubmed]  [Google Scholar] [DOI]
2 MR Imaging–Guided Focal Therapies of Prostate Cancer
Melvy Sarah Mathew,Aytekin Oto
Magnetic Resonance Imaging Clinics of North America. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Cognitive-Targeted versus Magnetic Resonance Imaging-Guided Prostate Biopsy in Prostate Cancer Detection
Daniël F. Osses,Joost J. van Asten,Jasper D. Tijsterman
Current Urology. 2017; : 182
[Pubmed]  [Google Scholar] [DOI]
4 MRI-guided focal therapy of prostate cancer
Melvy Sarah Mathew,Aytekin Oto
Future Oncology. 2016;
[Pubmed]  [Google Scholar] [DOI]
5 Molecular imaging and fusion targeted biopsy of the prostate
Baowei Fei,Peter T. Nieh,Viraj A. Master,Yun Zhang,Adeboye O. Osunkoya,David M. Schuster
Clinical and Translational Imaging. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 Impact of magnetic resonance imaging-guided prostate biopsy in the supine position on the detection of significant prostate cancer in an inhomogeneous patient cohort
Karl Engelhard,Reinhart Kühn,Artur Osten,Katja Bogner,Anton Dworak,Lars Lübke,Florian Schneider
Scandinavian Journal of Urology. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
7 The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation
Amanda Nicholson,James Mahon,Angela Boland,Sophie Beale,Kerry Dwan,Nigel Fleeman,Juliet Hockenhull,Yenal Dundar
Health Technology Assessment. 2015; 19(87): 1
[Pubmed]  [Google Scholar] [DOI]
8 Current role of multiparametric magnetic resonance imaging in the management of prostate cancer
Nikolas Christopher Katelaris,Damien Michael Bolton,Mahesha Weerakoon,Liam Toner,Phillip Mark Katelaris,Nathan Lawrentschuk
Korean Journal of Urology. 2015; 56(5): 337
[Pubmed]  [Google Scholar] [DOI]
9 The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation
Mahul B. Amin,Daniel W. Lin,John L. Gore,John R. Srigley,Hema Samaratunga,Lars Egevad,Mark Rubin,John Nacey,H. Ballentine Carter,Laurence Klotz,Howard Sandler,Anthony L. Zietman,Stuart Holden,Rodolfo Montironi,Peter A. Humphrey,Andrew J. Evans,Jonathan I. Epstein,Brett Delahunt,Jesse K. McKenney,Dan Berney,Thomas M. Wheeler,Arul M. Chinnaiyan,Lawrence True,Beatrice Knudsen,M. Elizabeth H. Hammond
Archives of Pathology & Laboratory Medicine. 2014; 138(10): 1387
[Pubmed]  [Google Scholar] [DOI]


Read this article